Blog

  • Eating only during the daytime could protect people from heart risks of shift work

    Eating only during the daytime could protect people from heart risks of shift work

    A study led by researchers at Mass General Brigham suggests that, when it comes to cardiovascular health, food timing could be a bigger risk factor than sleep timing

    Numerous studies have shown that working the night shift is associated with serious health risks, including to the heart. However, a new study from Mass General Brigham suggests that eating only during the daytime could help people avoid the health risks associated with shift work. Results are published in Nature Communications….

    Continue Reading


    News Source: www.sciencedaily.com

  • Targeted new approach to treat pancreatic cancer

    Targeted new approach to treat pancreatic cancer

    Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology study published today.

    Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest human cancers worldwide because it evades most treatments. With few therapeutic options,…

    Continue Reading


    News Source: www.sciencedaily.com

  • Even under stress, male-female pairs had each other’s backs

    Even under stress, male-female pairs had each other’s backs

    When faced with a potential threat, mice often freeze in place. Moreover, when two animals are together, they typically freeze at the same time, matching each other’s periods of immobility.

    In a new study, researchers found that coordination during fear looks different in males and females — and changes when stress is involved.

    Male-female mouse pairs consistently stayed in sync during stressful situations, even when the animals were strangers. Same-sex pairs were more likely to fall out of…

    Continue Reading


    News Source: www.sciencedaily.com

  • Viral ‘backbone’ underlies variation in rotavirus vaccine effectiveness

    Viral ‘backbone’ underlies variation in rotavirus vaccine effectiveness

    Researchers have shown that differences in the entire rotavirus genome — not just its two surface proteins — affect how well vaccines work, helping to explain why some strains are more likely to infect vaccinated individuals.

    The study, published today as a Reviewed Preprint in eLife, is described by the editors as an important paper. They say the novel approach to estimating rotavirus vaccine effectiveness provides convincing evidence that rotavirus vaccines should be designed based on…

    Continue Reading


    News Source: www.sciencedaily.com

  • Mimicking embryonic growth to break barriers in organoid research

    Mimicking embryonic growth to break barriers in organoid research

    Organoids are made to model human organs and are promising for research and therapy, but there are limitations in their growth and function. A recent study by researchers at The University of Tokyo found that placenta-derived IL1α under hypoxic conditions, can greatly increase growth of human stem cell-derived liver organoids. By promoting liver progenitor cell expansion through a specific signaling pathway, this method offers a promising route to improve organoid models and regenerative…

    Continue Reading


    News Source: www.sciencedaily.com

  • Netanyahu: I agreed with Trump to prevent Iran from possessing nuclear weapons.

    Netanyahu: I agreed with Trump to prevent Iran from possessing nuclear weapons.

    Israeli Prime Minister Benjamin Netanyahu announced on Tuesday that he …

    Continue Reading


    News Source: www.alquds.com

  • Long-term health impacts of flooding revealed

    Long-term health impacts of flooding revealed

    The world’s largest and most comprehensive study of the long-term health impacts of flooding — via analysis of over 300 million hospitalizations records in eight countries prone to flooding events — has found an increased risk of 26 per cent of all diseases serious enough to require hospitalization. This impact on the health of communities lasts up to seven months post event.

    The study, led by Monash University researchers, and published in the journal, Nature Water, found that flooding…

    Continue Reading


    News Source: www.sciencedaily.com

  • Researchers discover natural compound may slow ALS and dementia

    Researchers discover natural compound may slow ALS and dementia

    A natural compound found in everyday fruits and vegetables may hold the key to protecting nerve cells — and it’s showing promise as a potential treatment for ALS and dementia, according to new research from the University of Missouri.

    “It’s exciting to discover a naturally occurring compound that may help people suffering from ALS or dementia,” Smita Saxena, a professor of physical medicine and rehabilitation at the School of Medicine and lead author of the study, said. “We found this…

    Continue Reading


    News Source: www.sciencedaily.com

  • CVD and obesity: When protective lipids decline, health risks increase

    CVD and obesity: When protective lipids decline, health risks increase

    New research from Weill Cornell Medicine has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes — not the presence of certain fats, but their suppression. The study, published Feb. 25 in Nature Communications, challenges the conventional belief that a type of fat called ceramides accumulates in blood vessels causing inflammation and health risks. Instead, their findings reveal that when ceramides decrease in endothelial cells lining blood vessels, it…

    Continue Reading


    News Source: www.sciencedaily.com

  • ALS drug effectively treats Alzheimer’s disease in new animal study

    ALS drug effectively treats Alzheimer’s disease in new animal study

    Experimental drug NU-9 — a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) — improves neuron health in animal models of Alzheimer’s disease, according to a new Northwestern University study.

    Like ALS, Alzheimer’s disease also results from misfolded proteins that damage brain health. Rather than treating symptoms from specific diseases, NU-9 instead addresses the underlying…

    Continue Reading


    News Source: www.sciencedaily.com